v3.22.2.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 22,594 $ 47,217
Restricted cash, current 100 100
Marketable securities, current 47,540 7,226
Accounts receivable, net 20,253 20,128
Deferred sales commissions, current 3,079 2,691
Prepaid expenses and other current assets 5,140 6,151
Total Current Assets 98,706 83,513
Property and equipment, net 2,923 3,010
Goodwill 47,481 47,481
Intangible assets, net 17,518 20,195
Operating lease right-of-use assets 5,420 5,483
Deposits and other 427 664
Marketable securities, net of current 0 42,148
Deferred sales commissions, net of current 7,388 6,747
Deferred tax asset, net 131 0
Total Assets 179,994 209,241
Current liabilities:    
Accounts payable 4,123 6,490
Accrued expenses 12,786 13,855
Deferred revenue, current 1,249 1,307
Term loan, current 841 561
Operating lease liabilities, current 1,742 1,946
Finance lease liabilities, current 18 26
Total current liabilities 20,759 24,185
Long term liabilities:    
Deferred revenue, net of current 443 456
Term loan, net of current 53,839 54,459
Operating lease liabilities, net of current 4,043 4,046
Finance lease liabilities, net of current 0 11
Deferred tax liability, net 0 2
Warrant liability 633 767
Other long-term liabilities 338 337
Total liabilities 80,055 84,263
Commitments and contingencies (Note 9 and 21)
Stockholders’ equity:    
Preferred stock, $0.0001 par value per share; 25,000 shares authorized and none issued and outstanding as of September 30, 2022 and December 31, 2021. 0 0
Common stock, $0.0001 par value per share; 500,000 shares authorized and 92,506 shares issued and outstanding as of September 30, 2022; 500,000 shares authorized and 90,697 shares issued and outstanding as of December 31, 2021. 9 9
Additional paid-in capital 261,821 253,468
Accumulated other comprehensive loss (2,330) (477)
Accumulated deficit (159,561) (128,022)
Total stockholders’ equity 99,939 124,978
Total liabilities & stockholders’ equity $ 179,994 $ 209,241
Common stock, shares authorized (in shares) 500,000,000 500,000,000
Common stock, shares outstanding (in shares) 92,505,762 90,696,977
Common stock, shares issued (in shares) 92,505,762 90,696,977

Source